The global dicyclomine market is set to grow steadily over the next decade, supported by a persistent prevalence of irritable bowel syndrome (IBS), expanding access to generics, and incremental formulation advances that improve adherence, according to multiple industry analyses. Market assessments indicate global revenues in the broad dicyclomine category ranging from approximately USD 500...